Company intelligence / Profile preview

Friedli Corporate Finance

Zurich, Zurich, Switzerland

Ownership: Private
Development stage: Other

Overview

Friedli Corporate Finance is a Swiss venture capital firm specializing in the life sciences and biotechnology sectors. Founded by Peter Friedli, the firm provides strategic investment and corporate finance services to emerging healthcare companies. It has played a pivotal role in the funding and development of several notable biotech firms, including Newron Pharmaceuticals and Osiris Therapeutics. The firm typically targets high-innovation companies with the potential for significant clinical impact. Based in Zurich, Friedli Corporate Finance operates as a private investment vehicle focused on long-term value creation in the global healthcare market.

Industry: Investors

Beyond the preview

Go deeper on Friedli Corporate Finance.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Friedli Corporate Finance.

Explore the full profile